Deoxypyridinoline: Difference between revisions

From Food & Medicine Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
 
Line 1: Line 1:
'''Deoxypyridinoline''' (also known as '''DPD''') is a [[biochemical marker]] used in the medical field to measure the rate of [[bone resorption]]. It can be found in urine and blood tests and is useful in the diagnosis and management of various [[bone disease]]s, including [[osteoporosis]] and some [[cancer]]s.
== Deoxypyridinoline ==


== Overview ==
[[File:Deoxypyridinoline.svg|thumb|right|Chemical structure of deoxypyridinoline]]


Deoxypyridinoline is a [[pyridinium]] cross-linking [[amino acid]] that is released during the breakdown of [[collagen]], which is a major component of bone. The level of DPD in the body can provide insight into the rate at which bone is being broken down, which can be an indicator of bone disease.
'''Deoxypyridinoline''' (DPD) is a [[biochemical marker]] of [[bone resorption]]. It is a crosslinking compound found in [[collagen]] of [[bone]] and [[dentin]]. DPD is released into the [[bloodstream]] during the process of bone degradation and is subsequently excreted in the [[urine]].
 
== Structure and Function ==
 
Deoxypyridinoline is a [[pyridinium]] crosslink that stabilizes the [[collagen]] matrix in bone. It is formed by the enzymatic action of [[lysyl oxidase]] on [[lysine]] residues in collagen. The presence of DPD in bone provides structural integrity and resistance to tensile forces.


== Clinical Significance ==
== Clinical Significance ==


The measurement of DPD is often used in the diagnosis and management of diseases that affect bone metabolism, such as osteoporosis and [[Paget's disease]]. It can also be used to monitor the effectiveness of treatment for these conditions.
The measurement of deoxypyridinoline levels in urine is used as a marker for bone resorption. Elevated levels of DPD are indicative of increased bone turnover, which can occur in conditions such as [[osteoporosis]], [[Paget's disease of bone]], and [[hyperparathyroidism]].


In addition, elevated levels of DPD can be seen in certain types of cancer that spread to the bone, such as [[breast cancer]] and [[prostate cancer]]. In these cases, the measurement of DPD can help to assess the extent of the disease and the effectiveness of treatment.
=== Osteoporosis ===


== Measurement ==
In [[osteoporosis]], the balance between bone resorption and bone formation is disrupted, leading to a net loss of bone mass. Monitoring DPD levels can help assess the effectiveness of [[osteoporosis treatment]]s.


DPD is typically measured in urine, although it can also be measured in blood. The test is usually performed in a laboratory and involves the use of a special chemical that reacts with DPD to produce a color change. The intensity of the color change is then measured to determine the level of DPD in the sample.
=== Paget's Disease ===


== Limitations ==
[[Paget's disease of bone]] is characterized by excessive and disorganized bone remodeling. DPD levels can be significantly elevated in this condition, reflecting increased bone resorption.


While the measurement of DPD can provide valuable information about bone metabolism, it is not a definitive test for any particular disease. It is usually used in conjunction with other tests and clinical information to make a diagnosis.
=== Hyperparathyroidism ===


== See Also ==
In [[hyperparathyroidism]], increased secretion of [[parathyroid hormone]] leads to increased bone resorption. DPD levels can be used to monitor the severity of bone turnover in affected individuals.


* [[Bone metabolism]]
== Measurement ==
* [[Osteoporosis]]
* [[Paget's disease]]
* [[Breast cancer]]
* [[Prostate cancer]]


== References ==
Deoxypyridinoline can be measured using [[immunoassay]] techniques. Urinary DPD levels are often expressed relative to [[creatinine]] to account for variations in urine concentration. This measurement is non-invasive and provides valuable information about bone metabolism.


<references />
== Related Pages ==


{{stub}}
* [[Bone resorption]]
* [[Collagen]]
* [[Osteoporosis]]
* [[Paget's disease of bone]]
* [[Hyperparathyroidism]]


[[Category:Biochemical markers]]
[[Category:Biomarkers]]
[[Category:Bone diseases]]
[[Category:Bone physiology]]
[[Category:Medical tests]]
[[Category:Oncology]]

Latest revision as of 11:35, 15 February 2025

Deoxypyridinoline[edit]

Chemical structure of deoxypyridinoline

Deoxypyridinoline (DPD) is a biochemical marker of bone resorption. It is a crosslinking compound found in collagen of bone and dentin. DPD is released into the bloodstream during the process of bone degradation and is subsequently excreted in the urine.

Structure and Function[edit]

Deoxypyridinoline is a pyridinium crosslink that stabilizes the collagen matrix in bone. It is formed by the enzymatic action of lysyl oxidase on lysine residues in collagen. The presence of DPD in bone provides structural integrity and resistance to tensile forces.

Clinical Significance[edit]

The measurement of deoxypyridinoline levels in urine is used as a marker for bone resorption. Elevated levels of DPD are indicative of increased bone turnover, which can occur in conditions such as osteoporosis, Paget's disease of bone, and hyperparathyroidism.

Osteoporosis[edit]

In osteoporosis, the balance between bone resorption and bone formation is disrupted, leading to a net loss of bone mass. Monitoring DPD levels can help assess the effectiveness of osteoporosis treatments.

Paget's Disease[edit]

Paget's disease of bone is characterized by excessive and disorganized bone remodeling. DPD levels can be significantly elevated in this condition, reflecting increased bone resorption.

Hyperparathyroidism[edit]

In hyperparathyroidism, increased secretion of parathyroid hormone leads to increased bone resorption. DPD levels can be used to monitor the severity of bone turnover in affected individuals.

Measurement[edit]

Deoxypyridinoline can be measured using immunoassay techniques. Urinary DPD levels are often expressed relative to creatinine to account for variations in urine concentration. This measurement is non-invasive and provides valuable information about bone metabolism.

Related Pages[edit]